Axsome Therapeutics, Inc. (AXSM)

184.50 +7.23 (+4.08%) USD  |  NASDAQ  |  Jan 20, 16:00
181.68 -2.82 (-1.53%) Pre-Market: 08:56
More

Axsome Therapeutics Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade